Los Angeles Capital Management LLC Novo Cure LTD Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 70,601 shares of NVCR stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
70,601
Previous 15,267
362.44%
Holding current value
$1.5 Million
Previous $238,000
783.61%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
74.3MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$257 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$250 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$168 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$91.4 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$59.5 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.23B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...